comprehensive case study cancer patient and malnutrition n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Comprehensive Case Study: Cancer Patient and Malnutrition PowerPoint Presentation
Download Presentation
Comprehensive Case Study: Cancer Patient and Malnutrition

Loading in 2 Seconds...

play fullscreen
1 / 10

Comprehensive Case Study: Cancer Patient and Malnutrition - PowerPoint PPT Presentation


  • 307 Views
  • Uploaded on

Comprehensive Case Study: Cancer Patient and Malnutrition. Intern: Janna Neitzel Preceptor: Lori Houghtaling Facility: Albany Memorial Hospital Rotation: Clinical. Identification Information. Age: 67 Sex: Female Date of admission: 9/17/13 Admit HT and WT: 5’6”, 125#

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Comprehensive Case Study: Cancer Patient and Malnutrition' - robert-barr


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
comprehensive case study cancer patient and malnutrition

Comprehensive Case Study:Cancer Patient and Malnutrition

Intern: Janna Neitzel

Preceptor: Lori Houghtaling

Facility: Albany Memorial Hospital

Rotation: Clinical

identification information
Identification Information

Age: 67

Sex: Female

Date of admission: 9/17/13

Admit HT and WT: 5’6”, 125#

Weight classification: BMI 20.2—within normal limits

chief complaint
Chief Complaint
  • Admitting diagnosis:
    • Patient admitted with
      • nausea
      • vomiting,
      • UTI
    • Patient admitted 1 month prior
      • Back pain
history of present illness
History of Present Illness
  • History of colon and bladder cancer
  • Metastatic colon cancer with chemo
    • Cancer: group of diseases characterized by uncontrolled growth and spread of abnormal cells
      • Tumor growth and immune-mediated tumor destruction
      • Endogenous and exogenous risk factors exist for cancer development
    • Cancer is a genetic disease caused by chronic inflammation which elicits a chronic inflammatory response, eventually compromising the function ad structure of cells, creating uncontrolled proliferation (programmed cell death)
      • Endogenous factors: can initiate or promote development of cancer; free radicals, hormones, growth factors, specific genes (oncogenes)
      • Exogenous factors: lifestyle, environmental/occupational exposures, infectious organisms
  • Suspect poor nutrition prior to admit based on dietary recall
      • The National Cancer Institute and the American Cancer Society estimate that 1/3 of cancer deaths relate to poor dietary choices, physical inactivity, or obesity
      • Tobacco use accounts for additional 1/3 annual deaths from cancer
past medical history
Past Medical History

Colon cancer

Bladder cancer

Pyelonephritis

Uropsepsis

Cecal mass

CKD III

ARF

Symptomatic anemia

medications eating habits weight hx
Medications, Eating Habits, Weight Hx
  • Medications
      • Lopressor
      • Xanex
      • Mylanta
      • Dilaudid
      • Fentanyl patch
      • Cefepine
      • Megace
      • Colace
      • Ativan
  • Eating habits:
      • “Healthy” diet at home, unable to tolerate >1000cal/day, stated; restricts Na, K, and phosphorus intake/renal diet
      • Loss of appetite
  • WT Hx
      • UBW 142#
      • 120-125# @ admit
      • 112# most recent per bed scale
laboratory data
Laboratory Data
  • Current (12/5/13):
      • Low GFR
      • Low Na
      • Low Cl
      • Low Ca
      • High WBC
      • Low RBC
      • Low HGB
      • Low HCT
assessment
Assessment
  • Estimating needs:
    • 1600-1800kcal, 60-70g protein, 1.8L fluid per day
  • PES statement:
    • Suboptimal intake, unintentional WT loss, malnutrition in the context of chronic disease
  • Interventions:
    • Monitored intake at meals & reinforced importance of adequate intake
    • Provided magic cu/ ensure supplementation with meals
    • TPN rec—followed nutrition support team
    • Monitored WT and serial labs
plan of care
Plan of Care

Exhausted all efforts to meet patient’s nutritional needs PO

TPN discontinued due to patient request

Follow case manager plan for patient to transfer to nursing home

Hospice to consult

resources
Resources

Evidence Analysis Library and eatright.org

Copeiand, Edward M., Daly, John M., and Dudrick, Stanley J. Nutrition as an Adjunct to Cancer Treatment in the Adult. Cancer Research. 1977;37:2451-2456.

Tsai, Susan. Importance of Lean Body Mass in the Oncologic Patient. Nutrition in Clinical Practice. 2012;27(5): 593-598.

Vargas, Ashley J., Thompson, Patricia A. Diet and Nutrient Factors in Colorectal Risk. Nutrition in Clinical Practice. 2012;27(5): 613-623.

Ross PJ, Norton A, Priest K, Waters JS, Eisen T, Smith IE, O'Brien MER. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? British Journal of Cancer. 2004; 90: 1,905-1,911.

Capuano G, Grosso A, Gentile PC, Battista M, Bianciardi F, Di Palma A, Pavese I, Satta F, Tosti M, Palladino A, Coiro G, Di Palma M. Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head Neck. 2008 Apr; 30(4): 503-508.

Eriksson KM, Cederholm T, Palmblad JE. Nutrition and acute leukemia in adults: Relation between nutritional status and infectious complications during remission induction. Cancer. 1998; 82: 1,071-1,077.

Prado CM, Baracos VE, McCargar JL, Mourtzakis M, Mulder KE, Reiman T, Butter CA, Scarfe AG, Sawyer MB. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res. 2007 Jun 1; 13(11): 3,264-3,268.

Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, Mackey JR, Koski S, Pituskin E, Sawyer MB. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009 Apr 15; 15(8) :2,920-2,926.

Gottschlich, Michele M. The A.S.P.E.N. Nutrition Support Core Curriculum: A Case-Based Approach—the Adult Patient. Pg 651-671